Related Experiment Videos
Myelofibrosis in systemic lupus erythematosus
13rd Department of Internal Medicine, National Institute of Haematology and Blood Transfusion, Budapest, Hungary. kiss@iiibel.dote.hu
Leukemia & Lymphoma
|May 9, 2001
Summary
This case study details a rare instance of coexisting systemic lupus erythematosus (SLE) and myelofibrosis in a young female. Successful treatment using immunosuppressants and growth factors led to bone marrow recovery, avoiding transplantation.
Area of Science:
- Rheumatology
- Hematology
- Oncology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
- Myelofibrosis is a rare bone marrow disorder characterized by fibrosis.
- The co-occurrence of SLE and myelofibrosis is exceptionally rare.
Observation:
- A young female patient presented with pancytopenia and clinical manifestations meeting SLE criteria.
- Bone marrow biopsy confirmed severe myelofibrosis with myeloid hypocellularity.
- The patient exhibited symptoms indicative of both autoimmune and myeloproliferative conditions.
Findings:
- Treatment involved immunosuppressive therapy and colony-stimulating factors.
- The patient showed slow but complete bone marrow regeneration.
- Hematological status significantly improved post-treatment.
Implications:
- This case highlights a rare dual diagnosis of SLE and myelofibrosis.
- Demonstrates the potential efficacy of conservative management in such rare cases.
- Suggests that early intervention can lead to favorable outcomes, potentially avoiding bone marrow transplantation.